MAPT and Alzheimer disease: In contrast to the amyloid cascade hypothesis of AD, which implies that tau pathology is a secondary, downstream phenomenon, the neuropathological findings of Braak and collaborators have fueled a significant controversy concerning the importance or contributions of Aβ burden in producing damage compared to that caused by tau pathology.